Laboratorio de Parasitología, Centro de Investigaciones Regionales "Dr. Hideyo Noguchi", Universidad Autónoma de Yucatán, Mérida, Mexico.
Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, 77030, USA.
Exp Parasitol. 2023 Jun;249:108519. doi: 10.1016/j.exppara.2023.108519. Epub 2023 Mar 31.
Leishmaniasis is a vector-borne neglected tropical disease caused by the Leishmania spp. Parasite. The disease is transmitted to humans and animals by the bite of infected female sandflies during the ingestion of bloodmeal. Because current drug treatments induce toxicity and parasite resistance, there is an urgent need to evaluate new drugs. Most therapeutics target the differentiation of promastigotes to amastigotes, which is necessary to maintain Leishmania infection. However, in vitro assays are laborious, time-consuming, and depend on the experience of the technician. In this study, we aimed to establish a short-term method to assess the differentiation status of Leishmania mexicana (L. mexicana) using flow cytometry. Here, we showed that flow cytometry provides a rapid means to quantify parasite differentiation in cell culture as reliably as light microscopy. Interestingly, we found using flow cytometry that miltefosine reduced promastigote-to-amastigote differentiation of L. mexicana. We conclude that flow cytometry provides a means to rapidly assay the efficacy of small molecules or natural compounds as potential anti-leishmanials.
利什曼病是一种由利什曼原虫寄生虫引起的经媒介传播的被忽视热带病。这种疾病通过感染的雌性沙蝇在吸血时的叮咬,在人类和动物之间传播。由于目前的药物治疗会引起毒性和寄生虫耐药性,因此迫切需要评估新的药物。大多数治疗方法针对的是前鞭毛体向无鞭毛体的分化,这是维持利什曼虫感染所必需的。然而,体外检测既繁琐又耗时,并且依赖于技术人员的经验。在这项研究中,我们旨在建立一种使用流式细胞术评估墨西哥利什曼原虫(L. mexicana)分化状态的短期方法。在这里,我们表明流式细胞术可提供一种快速定量检测寄生虫在细胞培养中分化的方法,其可靠性与显微镜检查相当。有趣的是,我们发现使用流式细胞术,米替福新可减少墨西哥利什曼原虫的前鞭毛体向无鞭毛体的分化。我们得出结论,流式细胞术可提供一种快速检测小分子或天然化合物作为潜在抗利什曼原虫药物疗效的方法。
PLoS Negl Trop Dis. 2012-4-10
Exp Parasitol. 2019-4
Trop Biomed. 2019-12-1
Biochim Biophys Acta Biomembr. 2020-10-1
Int J Antimicrob Agents. 2019-7-16
Int J Parasitol Drugs Drug Resist. 2019-6-20
Lancet. 2018-8-17